High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
about
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokiStem-cell transplant preparative regimens.High-dose chemotherapy and autologous stem cell transplantation for breast cancer.A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer.High-dose etoposide in allogeneic stem cell transplantation.Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions.High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
P2860
Q28366611-59C36293-F609-4203-8BD2-14A912AC53F3Q33788170-32BF2D74-4BF0-46B5-967F-84CB73E75FFCQ33931132-345C6841-6AED-480D-B46A-4FDCB4A8368AQ34997356-10AC0B7F-CC64-4581-89BD-E1A2A29BB1E8Q36136361-2CFAB69A-A309-4E1B-8896-6C9D1DEDDCCAQ36140983-425A0BAF-FF61-44A9-856E-F8CD3C5DF7F8Q36624016-4C0E61E5-58D9-4A03-8BDD-564643089C6FQ38051016-FC015DBA-46C2-4B8C-8C44-1C4AF9C54BFFQ40865994-3C9C4ECA-DA35-4E1F-977E-3DC0BA4C28F6Q43561513-A300E50A-1BCD-4878-84A3-75E89EA97355Q43848133-9089B0D5-948F-4E5F-937A-A76D83833CAE
P2860
High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
type
label
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
prefLabel
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@nl
P2093
P1433
P1476
High-dose doxorubicin, etoposi ...... ope Bone Marrow Oncology Team.
@en
P2093
Doroshow JH
Margolin KA
Morgan RJ Jr
Nagasawa S
Raschko JW
P2860
P304
P356
10.1002/1097-0142(19940315)73:6<1678::AID-CNCR2820730621>3.0.CO;2-U
P407
P577
1994-03-01T00:00:00Z